Latest Breaking News On - Mark mcpartland - Page 1 : comparemela.com

Vistagen to Present at the 2024 American Society of Clinical Psychopharmacology Conference

Vistagen to Present at the 2024 American Society of Clinical Psychopharmacology Conference
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesMiami beachRita hanoverRossa bakerCaren scannellMark mcpartlandBrittany reedLouis montiEster salmanMichaelr liebowitzExchange commissionAmerican society of clinical psychopharmacology conferenceLaboratory ratsVistagen the companyCompany quarterly report on formClinical psychopharmacology conference

Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue

SOUTH SAN FRANCISCO, Calif., April 25, 2024 Vistagen (Nasdaq: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced positive results from a Phase 2A pilot study of PH15, an investigational pherine nasal spray, for improvement of psychomotor impairment caused by mental fatigue. PH15 demonstrated a statistically significant improvement in reaction time compared to placebo a

United statesMexico cityDistrito federalShawn singhMark mcpartlandJose maria calvoCaren scannellNational institute of psychiatryExchange commissionPherin pharmaceuticalsChief executive officerNational instituteSleep disorders clinicAssociate professorPrincipal investigatorNew drug

Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference

Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCaren scannellMichaelr liebowitzLouis montiBrittany reedMark mcpartlandRita hanoverEster salmRossa bakerDepression association of americaCompany quarterly report on formVistagen the companyExchange commissionDepression associationTop line resultsNasal spray

Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2

Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMark mcpartlandCaren scannellShawn singhCompany quarterly report on formExchange commissionChief executiveSubjective unitsDistress scaleFast trackAnnual reportQuarterly report

VistaGen Therapeutics, Inc (NASDAQ:VTGN) Q3 2024 Earnings Call Transcript

VistaGen Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.22, expectations were $-0.31.

Andrew tsaiMark mcpartlandPaul matisseShawn singhJosh princeCindy andersonVistagen therapeutics incChocolate companiesVistagen therapeuticsCall transcript februaryGen therapeuticsVistagen therapeutic fiscal yearQuarter financial resultsSenior vice presidentInvestor relationsChief executive officer